ZR2 Bioenergy (BSE 506640)₹127.50−0.39%Commodity Chemicals
In the Jun 2026 quarter (consolidated), ZR2 Bioenergy reported sales of ₹0 Cr and net profit of ₹0.21 Cr, down 30.0% year on year. For the year to Mar 2026, sales were ₹0 Cr and net profit ₹0.99 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.27 | 0.19 | 0.12 | 0.27 | 0.06 | 0.20 | 0.16 |
| Operating Profit | −0.29 | −0.21 | −0.14 | −0.27 | −0.08 | −0.22 | −0.18 |
| Other Income | 0.02 | 0.44 | 0.45 | 0.54 | 0.41 | 0.45 | 0.43 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.03 | 0.03 | 0.03 | 0.02 | 0.16 | 0.04 | 0.04 |
| Profit before tax | −0.28 | 0.24 | 0.32 | 0.29 | 0.21 | 0.21 | 0.22 |
| Tax % | 0.0% | 47.8% | 0.0% | 0.0% | −15.0% | 0.0% | 0.0% |
| Net Profit | −0.25 | 0.10 | 0.30 | 0.26 | 0.22 | 0.19 | 0.21 |
| EPS (Rs) | −0.74 | 0.32 | 0.88 | 0.77 | 0.65 | 0.14 | 0.15 |
| Mar 2022 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|
| Sales | 1.17 | 1.50 | 0.00 | 0.00 |
| Expenses | 1.12 | 1.86 | 0.67 | 0.69 |
| Operating Profit | 0.06 | −0.39 | −0.69 | −0.75 |
| OPM % | 4.3% | −25.5% | — | — |
| Other Income | 0.26 | 0.63 | 1.88 | 1.83 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.05 | 0.22 | 0.26 |
| Profit before tax | 0.33 | 0.22 | 0.99 | 0.93 |
| Tax % | −21.9% | 52.3% | −3.1% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.38 | 0.08 | 0.99 | 0.88 |
| EPS (Rs) | 2.45 | 0.26 | 0.64 | 1.71 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | — |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 0.35 | 0.35 |
| Reserves | 139 | 139 |
| Borrowings | 0.00 | 0.00 |
| Other Liabilities | 0.15 | 1.33 |
| Total Liabilities | 139 | 141 |
| Fixed Assets | 0.51 | 0.32 |
| CWIP | 119 | 120 |
| Investments | 0.00 | 0.00 |
| Other Assets | 20.06 | 20.84 |
| Trade receivables | 0.01 | 0.00 |
| Cash & equivalents | 19.08 | 18.83 |
| Total Assets | 139 | 141 |
| Mar 2022 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from operating activity | 0.90 | 30.98 | −0.68 |
| Cash from investing activity | 0.18 | −116 | 0.47 |
| Cash from financing activity | 0.00 | 100 | −0.03 |
| Net cash flow | 1.09 | 14.73 | −0.24 |
| Capex | 0.00 | 119 | 1.22 |
| Free cash flow | 0.90 | −88.20 | −1.91 |
| CFO / OP % | 1,780.0% | −8,171.0% | 97.0% |
| Mar 2025 | |
|---|---|
| Debtor days | 5 |
| Inventory days | 0 |
| Cash conversion cycle | 5 |
| Working capital days | 162 |
For the Jun 2026 quarter, ZR2 Bioenergy reported sales of ₹0 Cr and net profit of ₹0.21 Cr, down 30.0% year on year.
ZR2 Bioenergy's sales for the year to Mar 2026 were ₹0 Cr; over the last twelve months they were ₹0 Cr.
Net profit for the year to Mar 2026 was ₹0.99 Cr, and ₹0.88 Cr over the last twelve months. Earnings per share over the same trailing period were ₹1.71.
ZR2 Bioenergy reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹18.83 Cr.
Cash from operations was −₹0.68 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹1.91 Cr.